GeoVax Expands Gedeptin Strategy: Riding Merck’s Keytruda Wave in a $200 Billion IO Market -( $GOVX $MRK $IBB $XBI ) by John F. Heerdink, Jr. 2 days ago Read more Year of the Horsepower: Insulet’s Earnings Sprint and Modular Medical’s Quiet Canter -( $MODD $PODD ) by John F. Heerdink, Jr. 2 days ago Read more GeoVax Tries on Its 2026 “Breakout Year” Jacket — And It Might Just Fit -( $GOVX $IBB $XBI ) by John F. Heerdink, Jr. 3 days ago Read more The Big Mac Meets the Skinny Pill: How McDonald’s and Eli Lilly Are Sharing the Same Consumer -( $LLY $MCD ) by John F. Heerdink, Jr. February 12, 2026 Read more U.S. Stocks Propel Forward On Monday – February 9, 2026 -( $AVGO $DV $FLYX $META $NOK $NVDA $OKLO $OPEN $ORCL $PLTR $RIO $TSLA $TSM Rise!) by John F. Heerdink, Jr. February 10, 2026 Read more Eupraxia Pharmaceuticals: Injecting New Life Into EoE — One Microsphere at a Time -( $EPRX $SNY $XBI ) by John F. Heerdink, Jr. February 9, 2026 Read more Eli Lilly’s Weight-Loss Empire Just Got Heavier with $2.4B Acquisition – And So Did Its Market Cap -( $LLY $NVO $SPY ) by John F. Heerdink, Jr. February 9, 2026 Read more Dow Breaks 50,000 as Wall Street Limps, Then Leaps Into the Weekend – February 6, 2026 -( $DIA $EPRX $FLYX $LLY $MCD $MANE $MODD $NOK $RIO Rise!) by John F. Heerdink, Jr. February 6, 2026 Read more Can Modular Medical Crack the “Almost‑Pumper” Code? Inside the Bull Case for MODD’s Pivot System -( $MODD $PODD $TNDM ) by John F. Heerdink, Jr. February 6, 2026 Read more Stock Market Trades Like a Slightly Over-Caffeinated & Negative Economist – February 5, 2026 -( $MODD $PAHC $VIX Rise!) by John F. Heerdink, Jr. February 6, 2026 Read more Read more
